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Abstract: 
     Tissue engineering is a scientific methodology that provides the means for fabrication of vital 
tissues in a laboratory with the ultimate goal of translating the tissue to a patient in a clinic.  It is 
a desirable technique in clinical medicine because it eliminates the need for patient tissue grafts 
and transplants, which have the potential for donor site morbidity and rejection.  In tissue 
engineering, the scaffolding material, typically a polymer upon which tissue is grown, is 
important.  The goal of this research is to investigate optimization of tissue-engineered polymer 
scaffold constructs for cell proliferation and gene expression.  This work includes an analysis of 
scaffold type to determine the appropriate engineered materials for growing human periosteum.  
Many scaffolding materials have been investigated for tissue-engineering purposes; however, the 
present study will be examining novel scaffolds for growing periosteum, those scaffolds being 
composed of hydroxyapatite (HA) or beta-tricalcium phosphate (β -TCP) with polylactic 
acid/polycaprolinic acid [P(LA/CL)].  To conduct this analysis, histology of tissue-engineered 
constructs will be utilized to determine cell proliferation, and reverse transcription-quantitative 
polymerase chain reaction (RT-qPCR) will be applied to determine gene expression of construct 
cells.  Results will be compared to determine differences in fold-change expression levels of 
several genes of interest that may be affected by the two different scaffolds.  The initial findings 
of the study showed that there were few significant differences in gene expression between the 
scaffolds composed of HA or β -TCP. 
Introduction: 
     Tissue engineering is an experimental technique used to augment, replace, and repair 
congenitally defective, damaged, or missing tissues.  Initially proposed by Langer and Vacanti in 
1993, tissue engineering has become widely implemented to regenerate a variety of tissues, 
including mineralized connective tissues such as cartilage and bone.1  Before tissue engineering 
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was developed, the common method of replacing or repairing tissues involved prosthetics, 
transplanting foreign tissues, or grafting tissues from other parts of the body of the patient.  
While still practiced, prosthesis, transplantation, and grafting often lead to tissue rejection and 
inflammation as well as donor site morbidity.  This study will be examining novel scaffolds as 
potential improvements for tissue engineering of bone and ultimately for advancing methods 
beyond transplantation and grafting. 
     The tissue engineering of constructs involves three principle aspects, a source of cells, an 
appropriate and biocompatible scaffold material, and possible application of cytokines and 
growth factors.  The major cells and tissues involved in this study include bone, cartilage, and 
periosteum. 
     The human skeleton, which gives the body a rigid framework, is composed principally of 
bone.  In addition to serving as an attachment point for soft tissues, the skeleton provides a 
means for locomotion, furnishes protection to otherwise vulnerable organs such as the brain and 
the lungs, and acts as a calcium reservoir, depositing or absorbing calcium as the body demands.  
Bone contains other ions, such as sodium and phosphorous, and can also accumulate or release 
these to maintain ionic homeostasis in the fluids of the body.2 
     The process of bone growth is referred to as ossification.  There are two types of ossification:  
endochondral and intramembranous.  They are distinct from each other, but bones formed by the 
two different processes exhibit the same histologic structures3 (to be explained later).  
     Endochondral ossification3 is the process by which most bones of the body develop.  The 
endochondral course of growth involves the formation of a temporary hyaline cartilage model.  
This model precedes bone formation and allows bone to increase in size by interstitial and 
appositional means.  The chondrocytes in hyaline cartilage divide, mature, and hypertrophy 
(swell), then begin to calcify.  The calcified matrix serves as the structural framework for the 
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development of bone.  Bone is generated as a result of the invasion of hypertrophic cartilage by 
vascularity, which brings in new cells that erode the chondrocytes and replace them with 
osteoblasts.  As cartilage is replaced by bone material, a surrounding layer of connective tissue 
called periosteum is formed simultaneously at the bone surface.  Periosteum contains the cells 
needed to grow bone, including osteoprogenitor cells of both chondrocytes and osteoblasts, 
again, at the bone surface.  This process is called intramembranous, or appositional, ossification.  
     Intramembranous ossification3 occurs when bones grow not from a cartilage model, but from 
a precursor connective tissue called mesenchyme.  Some mesenchyme cells, known as 
mesenchymal stem cells, differentiate into osteoblasts, which secrete extracellular matrix 
proteins that have the capacity to induce bone formation.  Once surrounded by this matrix and 
upon its subsequent calcification, osteoblasts become enclosed or reside within small cavities 
termed lacunae.  At this point osteoblast function is diminished, and operationally these cells are 
considered osteocytes.  Osteocytes now begin to establish connections with neighboring 
osteocytes, osteoblasts, and osteoclasts (bone-resorbing cells) through multiple canaliculi, small 
canals that provide a means for cell-to-cell communication.  This process of ossification forms 
the mandible, maxilla, clavicles, and flat bones of the skull. 
     Cartilage is a specialized type of connective tissue often associated with bone.  The firm 
consistency of the extracellular matrix secreted by chondrocytes, or cartilage cells, gives this 
tissue the ability to bear mechanical stress without permanent distortion.3  This property of 
cartilage occurs because its matrix is rich in glycosaminoglycans and proteoglycans, which 
interact with collagen and elastic fibers to impart shock-absorbance.  This tissue also provides a 
sliding area for joints and facilitates bone movement.  There are three forms of cartilage, hyaline 
(the most common form), elastic, and fibrocartilage.  Each type maintains certain individual 
properties, but all three share the fact that they are avascular and must be nourished by diffusion 
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of nutrients from surrounding capillaries.  These capillaries are found in adjacent connective 
tissue, known as perichondrium.  Chondrocytes play an essential role in the development of long 
bones.  Every long bone contains a growth plate, which is responsible for interstitial bone 
growth.  The growth plate is composed of four zones of cartilage.  The zone of reserve cartilage 
is located closest to the joint, and is made up of resting chondrocytes.  Immediately below the 
reserve cartilage is the zone of proliferating chondrocytes.  This layer consists of cartilage cells 
in the process of dividing and forming cellular columns.  The nuclei and cytoplasm of these 
chondrocytes increase in size and the cells swell, creating the zone of hypertrophy.  The 
hypertrophied cells begin to break down and form thin plates of calcified cartilage as noted 
above.  Below this calcifying layer, bony material is deposited on the calcified matrix, creating a 
zone of provisional ossification.  This zone is ultimately responsible for the growth of the long 
bone, as it is the template or stratum where the new bone forms.3   
     Periosteum is a thin membrane, both fibrous and cellular, that covers the surfaces of all bones.  
The outer fibrous layer is composed in part of fibroblasts and collagen, the collagen extending 
through the periosteum and into the bone matrix.  These Sharpey’s fibers, as the collagen fibers 
are often called, provide the periosteal layer with a strong anchor and tight bond to the bone.  
The inner cambium layer of the periosteum is cellular, made up of fibroblast-like cells known as 
osteoprogenitor cells.  These cells, as their name suggests, have the potential to divide and 
differentiate into osteoblasts, the bone-forming cells.  The progenitor cells have the ability to 
respond to various chemical signals and can develop into chondrocytes if necessary.  The 
periosteal layer is highly vascularized, and it is responsible for providing nourishment to the 
bone.  The periosteum plays an important role in bone remodeling and is responsible for the 
appositional growth of bone as described above.9   
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     The Landis Laboratory has previously investigated gene expression of human periosteum 
applied to certain polymer scaffolds for tissue engineering.1,4,5,6  This work involved use of human 
donor cadaveric tissue that was composed of periosteum (bone and cartilage cells as just 
detailed).  The periosteum was wrapped about polymer scaffolds and incubated in athymic 
(nude) mice for times up to 60 weeks.  The periosteum-scaffold constructs were retrieved after 
implantation and analyzed in part for their gene expression using the method of reverse 
transcription-quantitative polymerase chain reaction (RT-qPCR) analysis.  Constructs are 
assemblies that consist of cells or tissues applied to a substrate or scaffold, commonly a polymer.  
These constructs are then used to augment, replace, and repair tissues, as discussed earlier.  The 
purpose of the scaffolding for engineering the tissues is to guide cell attachment, migration, 
proliferation, differentiation, and tissue regeneration. 
     In the current research, a similar project will be undertaken; however, it will examine 
scaffolds that have not previously been studied.  The purpose of investigating these scaffolds is to 
determine which mineral component increases gene expression of bone- and cartilage-specific 
genes.  Periosteum will be wrapped about polymer scaffolds of 70% hydroxyapatite/30% 
polylactic acid/polycaprolinic acid (50/50) [HA70%P(LA/CL)] and 3% β -tricalcium 
phosphate/97% polylactic acid/polycaprolinic acid (50/50) [TCP3%P(LA/CL)].  As stated, the 
purpose of the scaffolding is to guide cell and tissue growth.  The scaffold material must be 
porous, to allow nutrients and metabolites to penetrate through it, and it may be conducive to 
vascularization of the tissue.2   
     Often, PLA and PCL are used as the basic polymers comprising tissue-engineering scaffolds.  
They are desirable because of their ability to degrade and resorb in the body, avoiding long-term 
complications or rejection since they are biocompatible.2  These materials can be combined with 
other components, such as HA or β -TCP minerals (in the case of the current research) to aid in 
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the engineering of new tissue and impart strength to the scaffolds.  Combination with these 
minerals may have effects on the growth and gene expression of the tissue as two possible 
outcomes of interest in this study. 
     Work in other laboratories has been done examining HA as a component of tissue-engineering 
scaffolds.  With HA being a major component of the inorganic portion of bone, HA-laden 
scaffolds can serve as a site for new bone deposition.  As a synthetic polymer with HA begins to 
disappear on resorption, the mineral has the ability to contribute to and integrate into the newly 
forming bone.2  In one study, a porous HA/PLLA scaffold and a pure PLLA scaffold were seeded 
with osteoblasts to determine differences in a number of cell parameters as a function of HA 
presence.  Results ultimately favored the HA-containing scaffold:  The researchers found that the 
HA scaffold led to a larger percentage of cell survival, more uniform osteoblast distribution with 
deep penetration into the scaffold, and higher expression levels of the bone-specific genes, bone 
sialoprotein (BSP) and osteocalcin (OC).  These results indicate that HA as a component of a 
tissue-engineering scaffold imparts osteoconductivity,2 meaning the mineral is able to help guide 
the regeneration and repair of the natural bone.  HA is useful in tissue engineering because of its 
osteoconductive properties, but it may not be useful in other situations.  For example, when used 
simply as a bone graft without any engineered tissue, HA is minimally absorbed by the body, and 
its presence blocks any formation of new bone and prevents bone remodeling.  This result often 
leads to reduced stability at the site of the graft and permanent stress concentration in that area.8 
     β - TCP is the other mineral component used to create the scaffolding in this research project.  
Little work has been done investigating the function of β -TCP when seeded with cells or tissues, 
but studies have examined uses of this polymer simply as a bone grafting material.  As a bone 
graft, β -TCP holds an equivalent balance between scaffold absorption and bone formation.  As a 
biodegradable ceramic material, it has the ability to supply both calcium and sulfate ions to the 
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body as well as provide a solid scaffold structure for bone regeneration.  For these reasons, β -
TCP is useful as a bone graft, but in terms of tissue engineering, it lacks osteoconductivity and 
osteogenicity, which may hinder its application in the current study.8  Osteogenicity is a function 
of living bone cells in the scaffold to contribute to bone healing and remodeling. 
     The periosteum used in this research was obtained from the femur of a deceased 16-year old 
male.  In addition to periosteum, chondrocytes were taken from the donor joint.  Periosteum was 
dissected into small strips that were wrapped about either the HA- or β -TCP-scaffolds, shaped as 
rectangular solids, approximately 1 X 0.5 X 0.5 cm.  The construct to be fabricated in these 
studies is a model of a human distal phalanx.  This model consists of a midshaft (HA- or β -TCP-
scaffolds wrapped with periosteum) and one cartilage endplate.  The endplate in the model is 
constructed of chondrocytes seeded onto polyglycolic acid (PGA) sheets, approximately 1 X 1 X 
0.2 cm.  Periosteum-wrapped midshafts were prepared by placing the constructs in M199 culture 
medium at 37°C at 5% CO2 for five days.  To prepare chondrocyte-seeded PGA sheets, 
chondrocyte suspensions in Ham’s F12 medium were seeded onto PGA sheets and incubated for 
four hours at 37°C and 5% CO2 to allow cells to adhere to PGA.  At this point, additional Ham’s 
F12 medium was added, and samples were incubated for five days.  After incubation, 
chondrocyte-seeded PGA sheets were sutured with 5.0 Vicryl thread to the ends of the 
periosteum-wrapped scaffolds.  The complete model constructs were placed in Petri dishes and 
incubated in M199 culture medium at 37°C at 5% CO2 for 24 hours. Following incubation, the 
constructs were implanted in nude mice and grown for periods of 5 and 20 weeks.  Nude mice 
have no thymus and therefore a suppressed immune system.  As a result, these animals can 
accept and grow tissues from other species since the mice have a compromised immune system.  
The animals may then serve as bioreactors to assist in understanding the development of the 
implanted human constructs used in this study.  After the 5- and 20-week incubation periods, the 
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constructs were retrieved from the mice.  They were ground to a powder in liquid nitrogen, and 
their RNA was isolated.   
     Remaining research will involve investigation of construct gene expression using RT-qPCR.  
Five genes will be of interest:  BSP, type I collagen, type II collagen, OC, and osteonectin (ON).  
BSP is important to examine because it is a prominent component of mineralized tissues such as 
bone and calcifying cartilage.  BSP is composed of 327 amino acids, with the mature protein 
weighing 33-34 kDa.14  The protein contains long stretches of glycine and glutamic acid residues, 
which are believed to play a role in the ability of BSP to serve as a nucleation site for HA.7  
Another prominent gene expressed by cells of mineralizing tissues is type I collagen.  The most 
abundant form of collagen in the body, type I collagen as a protein makes up the organic portion 
of bone, for example, and imparts tensile strength within this tissue.  Type I collagen protein 
consists of three coiled subunits: two α 1 chains and one α 2 chain.  Each chain is made of 1039 α
amino acids,17 and the three chains wind around one another to form a right-handed helix.  Triple 
helices are the primary structural units of collagen fibers and occur because of the large number 
of glycine, proline, and hydroxyproline residues.10  In addition to type I collagen, the gene 
expression of type II collagen will be studied.  Type II collagen protein, at 1487 amino acids 
long,15 is the principal component of hyaline cartilage, (articular, growth plate, nasoseptal, and 
costal cartilage), elastic cartilage (auricular), and fibrocartilage (joining tendon or ligament to 
bone).  Articular cartilage covers bone surfaces at articulating joints, and the chondrocytes used 
in the current research were obtained from this type of joint.  OC is another gene of interest.  The 
counterpart of this gene is a noncollagenous protein found in most normally and abnormally 
mineralizing vertebrate tissues and often studied in tissue-engineered bone.2  Numbering between 
47 and 51 amino acids (depending on species), OC is a calcium-binding protein expressed 
abundantly in the organic matrix of bone.11  Specifically, OC is expressed and secreted by 
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osteoblasts and chondrocytes and therefore can be used as a marker for bone and cartilage 
formation.  Expression of the ON gene, which leads to production of its glycoprotein in bone that 
binds calcium with high affinity, will also be examined.  ON is a 32 kDa bone-specific protein, 
coded for by 286 amino acids.12,13  It has a high affinity for calcium ions, HA, and type I collagen, 
which leads to the hypothesis that ON may play a role in regulating bone mineralization.13  
However, some studies have shown that ON glycoprotein inhibits HA formation and growth.7 
 The expression of these genes of interest in the tissue-engineered constructs will be compared 
to determine which scaffold type yields an engineered tissue with higher levels of human bone 
and cartilage genes.  The engineered tissue must be as similar as possible to the endogenous 
human tissue, so as to minimize the potential that the recipient may reject the new tissue.  
     In addition to analyzing the gene expression in the tissue-engineered constructs, their 
histology will be studied.  Histology provides a means to examine the morphology of tissue 
specimens and can aid in determining the location and relative amounts of their various 
components.9  In medicine, histopathological examination can indicate a disease state or other 
abnormality if irregular cells or tissues are observed within a specimen.  A multitude of different 
histological stains can be employed, and each can be used to elucidate a different type of cellular 
component.  A drawback of using traditional histology to examine tissues is that typically tissues 
are chemically fixed, and the fixation process precludes investigations of dynamic events and 
metabolic functioning.   
     To prepare a tissue for histologic examination, the tissue must be properly fixed.  Fixation is 
the preservation of structure and molecular composition of tissues.  Ideally, tissues should be 
fixed as quickly as possible on retrieval from a sample.  Fixation avoids tissue degradation that 
normally occurs by enzymatic or bacterial action at the point of tissue death.  Various chemical 
fixatives are available for tissue preservation.  Fixatives act by cross-linking proteins, thus 
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stabilizing the tissues.9  After fixation, the tissue must be embedded in a solid medium for 
sectioning.  There are different ways to embed a sample depending on which type of microscopy 
is being used ultimately to examine the tissue.  Paraffin wax is used to embed samples that will 
be examined with light microscopy, and plastic resin is used to embed those to be viewed by 
electron microscopy.  Once the tissue is embedded, it may be sectioned.  Paraffin sectioning 
involves cutting tissues into extremely thin (1-10 µm) slices with an instrument called a 
microtome.  Sections are collected with forceps, floated on water, and transferred to glass slides.9 
     Another method available to prepare tissues is rapid freezing, in which they are fixed by being 
quickly frozen and subsequently sectioned with a cryostat.  Rapid freezing is useful in studying 
sensitive enzymes, small molecules, lipids, or specimens that must be examined rapidly, such as 
tissues removed during surgery and in a non-chemically fixed state.9 
     Once transferred to glass slides, the tissue sections are stained.  Various types of stains can be 
employed to provide information about different structures within the tissue.9   The stain used in 
the current experiments is toluidine blue (T-blue), a basic dye that has a high affinity for acidic 
cellular components and general cellular morphology.  With T-blue staining, chondrocytes stain 
pink and periosteum stains blue for the studies here. 
     A model of bone growth and 
development is applicable to 
understanding tissue-engineered 
bone in this project.  In Figure 1, 
the histological image illustrates 
how growth of a long bone occurs.3  
As stated previously, long bone 
growth occurs through 
Figure 1.  Taken from reference 2. A histologic image 
illustrating how long bone growth occurs.  The various 
zones of growth and cell types are labeled. 
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endochondral ossification.  Growth plates constitute the ends of long bones of the body and are 
responsible for longitudinal bone growth.  For an explanation of the growth plate, see Page 5.  
Figure 1 shows the zone of reserve cartilage (1), the zone of proliferating chondrocytes (2), and 
the zone of chondrocyte hypertrophy and calcification (3).  Ossification (4) occurs immediately 
below the zone of calcified cartilage, and bony material is deposited on the plates of calcified 
cartilage matrix.  The diaphysis of the bone is covered by a periosteal layer (also previously 
explained) and is responsible for appositional growth of bone.  Histological examination can help 
illustrate all these various bone and cartilage regions and provides a method for close 
investigation of tissue.3 
     As with all research, the current study does not come without experimental limitations.  For 
example, in order to determine the efficacy and validity of this method, rigorous and repeated 
tests and trials must be completed successfully, and these can frequently pose complications.  
Since live cells taken directly from a patient are not readily accessible, the tissues to be used in 
this project must be obtained, with appropriate permissions, from donor cadavers.  Even when 
harvested within 24 to 48 hours after donor death, cells are occasionally not viable because of 
natural degradative processes.  Testing of harvested cells applied to scaffolds must be done 
carefully and involves demonstration that the constructs develop in the same way as their normal 
tissue counterparts.  Validation of the developing construct is provided by examining it after 
implantation and retrieval from the nude mouse, and this examination can be accomplished using 
the techniques of histology and RT-qPCR (as will be done in the current study).  Absolute 
certainty in the ability of the construct cells to express the desired genes must be obtained and 
proven repeatedly, and this requirement is another limitation in the tissue engineering 
methodology.  Further, in a typical clinical application for tissue engineering, cells from a living 
patient are used, but harvesting those cells may cause morbidity at the site of collection, a 
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possibility that also may limit the experimental approach.  Constructs must then be grown in the 
patient, a procedure that can cause risk of erosion or migration of the implant, in addition to 
exposure to possible infection.  All these factors are yet more constraints to the tissue 
engineering technique. 
     Despite the limitations that exist, this project may offer significant clinical benefits to 
patients.  If completed successfully with mice and moved to human trials in the future, the work 
here could help grow tissues that individuals have lost, such as severed fingertips, or have had 
injured or damaged.  The tissue-engineering regime outlined in this study would not only regrow 
impaired, defective, or absent tissues, but also grow them accurately as compared to their 
endogenous human tissue counterparts.  This approach ensures that the correct scaffold is used to 
support cells and genes of interest closest to those appearing in normal human bone. 
Materials and Methods 
All protocols were obtained from the Landis Laboratory and are summarized below. 
RT-qPCR preparation: Freeze-grinding samples      
     To grind tissue samples, a freezer mill (Model 6870, Spex, Swedesboro, NJ) was filled with 
liquid nitrogen an hour before use to provide for sufficient cooling time for the instrument.  
Constructs were thawed on ice after removal from the -80°C freezer.  Samples were removed 
individually from respective tubes using clean tweezers, rinsed in diethyl pyrocarbonate (DEPC) 
water to prevent RNase activity, and quickly submerged in liquid nitrogen.  Constructs were 
placed into grinding tubes, each containing a cylindrical magnet, and tubes were sealed with a 
cap.  Once the tubes containing samples were in the freezer mill, cycles were run as follows: 15-
min pre-cool and three grind cycles of 2 min each.  Upon completion of each cycle, tubes were 
removed from the instrument.  Ground construct powder was emptied into pre-labeled 50-mL 
cylindrical tubes, containing 3 mL of TRI reagent (guanidinium thiocyanate-phenol-chloroform, 
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Molecular Research Center, Cincinnati, OH), maintained at 4°C on ice.  Each tube was shaken 
and vortexed briefly to ensure mixing of construct powder with TRI reagent.  Samples in tubes 
were then homogenized (See below) or refrozen at -80°C and stored. 
 Homogenization and phase separation     
     Homogenization and phase separation of the samples was performed on only four samples at 
a time.  Ground and powdered samples stored in TRI reagent were removed from the -80°C 
freezer and were thawed on ice, vortexing intermittently.  Tubes were placed into a refrigerated 
µSpeedFuge tabletop centrifuge (Savant, Midland, MI) and spun at 2000 rpm and 4°C for 8 min.  
Supernatant was transferred into three 1.5-mL centrifuge tubes containing 1 mL each.  Each 1.5-
mL tube was vortexed and left at room temperature for 4 min.  Tubes were supplemented with 
100 µL bromochloropropane (BCP, functioning as a phase-separation reagent) per 1 mL of TRI 
reagent.   Tubes were vortexed for one minute.  Samples were placed on ice for 15 min and then 
centrifuged at 13,000 g and 4°C for 30 min.  During centrifugation, the mixture separated into a 
lower red-colored phase (protein), a white interphase (DNA), and an upper aqueous phase 
(RNA).  The upper phase was pipetted and transferred to a fresh tube and supplemented with an 
equal portion of isopropanol, which in the current experiment was 750 µL.  Next, two µL of 
glycogen were added to each tube to function as an inert carrier, free of any host genomic 
material.  Samples were stored in a -80°C freezer.   
RNA wash  
     Samples were washed to remove impurities possibly present in their RNA.  Samples were 
removed from the -80°C freezer and spun at 13,000 g and 4°C for 30 minutes.  Each tube was 
properly oriented in the centrifuge well, ensuring that the tab of the tube aligned with the back 
mark of the well.  Following centrifugation, alcohol was carefully poured off the pellet, which 
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was concentrated at the bottom of the tube and whitish in color.  In some cases the pellet did not 
remain at the bottom of the tube, and instead it was loose and tended to slide when alcohol was 
being removed.  In these cases, alcohol was pipetted carefully and discarded.  Next, 1000 µL of 
70% EtOH/DEPC water (35 mL ethanol and 15 mL DEPC water, stored at -20°C) were added, 
and each tube was inverted several times to wash the pellets.  Tubes were spun at 13,000 g and 
4°C for 5 min.  The wash was carefully removed from the pellet by pouring, if possible, and 
discarded.  After this, 500 µL of 70% EtOH/DEPC were then added to the tubes, again inverting 
and washing the pellet.  Tubes were spun at 13,000 g and 4°C for 5 min, and wash was poured 
off.  Last traces of liquid were removed with a pipette and tubes were dried under a heat lamp for 
5 min.  Next, 350 µL of lysis buffer (EZNA Total RNA Kit I, Omega Bio-Tek, Norcross, GA) 
were added to each sample, followed by 350 µL of 70% EtOH/DEPC water at room temperature, 
which was pipetted repeatedly to ensure proper mixing.  Each sample was then placed on a 
HiBind RNA spin column seated in a 2-mL collection tube and centrifuged in an Eppendorf 
5424 Centrifuge at 10,000 g for 60 sec (Eppendorf, Hauppauge, NY).  The flow-through (FT) 
was discarded and the collection tube was reused in the next step, where 250 µL of RNA Wash 
Buffer I were added to each sample by pipetting directly onto the column, still seated in a 2-mL 
collection tube.  Again, tubes were centrifuged at 10,000 g for 60 sec and FT was discarded.  At 
this step, a stock solution of DNase I was created using the following recipe: 294 µL EZNA 
DNase I digestion buffer (obtained from the kit) mixed with 6 µL of RNase-free DNase I 
(Omega, Norcross, GA).  RNA columns were placed into new 2-mL collection tubes, and 75 µL 
of the DNase solution were pipetted onto the center of the column membranes.  The columns 
were then incubated at room temperature for 15 min.  Then, 500 µL of RNA Wash Buffer I were 
added, tubes sat at room temperature for 2 min, and were spun at 10,000 g for 60 sec.  FT was 
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discarded and collection tubes were reused, then 500 µL of RNA Wash Buffer II were added, 
and tubes were spun at 10,000 g for 60 sec.  Before using RNA Wash Buffer II, the solution was 
diluted with ethanol and brought to room temperature.  FT was discarded and the wash was 
repeated.  After the second wash with RNA Wash Buffer II, columns were spun with the empty 
collection tubes at 10,000 g for 2 min to dry.  Columns were placed in clean 1.5-mL centrifuge 
tubes, properly labeled.  Next, 40 µL of DEPC water were added directly to the center of column 
membranes.  Columns sat for 1 min, and then they were spun at 10,000 g for 2 min.  RNA was 
now in each centrifuge tube, as the DEPC water removed it from the column.   
Quantitation of RNA  
    Once RNA had been isolated and purified, it was quantitated.  Spectroscopic analysis was 
performed using an Eppendorf Biophotometer 6131 (Eppendorf, Hauppauge, NY).  A clean 
cuvette was obtained and filled with 50 µL of 1X TE Buffer.  The 1X TE buffer was made by 
mixing 10 mM Tris (brought to pH 8.0 with HCl) with 1 mM ethylenediaminetetraacetic acid 
(EDTA).  The purpose of this buffer was to solubilize RNA (or DNA) while protecting it from 
degradation.  TE buffer was stored at -20°C.  The Biophotometer was set to analyze RNA.  The 
instrument was blanked with the cuvette containing TE buffer.  The cuvette was removed and 1 
µL of sample was added.  After wiping the sides of the tube with a KimWipe to eliminate the 
possibility of error because of an unclean cuvette, the cuvette was inserted into the holder, and 
the “sample” button was pressed.  Spectroscopic analysis provided data indicating how pure 
samples were and how much RNA was present in each sample.  
Reverse Transcription 
     Reverse transcription was begun by creating a buffer mix.  The amount of buffer needed was 
dependent on the number of samples being reverse-transcribed.  A volume of 8.5 µL of buffer 
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was required for each tube.  The number of tubes needed was calculated by adding together the 
number of samples, a negative control for each sample (no reverse transcriptase), and a buffer 
blank (no RNA).  The buffer recipe was as follows (Life Technologies, Grand Island, NY): (per 
tube) 2 µL of 10X buffer, 4 µL dNTPs (dinucleotide triphosphates), 1 µL oligo dT, 1 µL random 
hexamers, 0.5 µL RNase inhibitor (RI).  Reaction components were added in the order listed.  
After addition of all ingredients, tubes were gently vortexed and centrifuged to concentrate 
buffer mix.  The amount of RNA and DEPC water added to each tube was equal to 10.5 µL, and 
one µg of RNA was needed for each reaction.  Using concentration obtained from the 
spectrophotometry data, µL of RNA were calculated.  DEPC water was added to 10.5 µL to 
account for total volume. With no more than six tubes at a time, tubes were labeled with sample 
number, experiment number, species, date, and cDNA.  To clean tubes, DEPC water was added 
first, according to calculations detailed above.  Second, 8.5 µL of buffer mix were added to each 
tube.  RNA was added last to each tube.  Tubes were vortexed and spun, then gently set into a 
65°C heater for 5 min.  Next, tubes were placed in a clean RNase-free rack at room temperature 
for 10 min.  After allowing the tubes to sit at room temperature, 1 µL of reverse transcriptase 
was added to each tube (except for the negative controls) and mixed with the pipette tip.  The 
tubes were allowed to sit at room temperature for an addition 10 min.  Next, they were moved to 
the 37°C heater block for one hr.  To destroy any RNA that may not have been reverse-
transcribed, samples were placed at 95°C for 5 min, then cooled on ice.  At this point, the tubes 
contained cDNA, and they were stored separately from RNA tubes at -80°C.  In addition to 
reverse-transcribing samples, standard concentrations of control tissues were also reverse-
transcribed.  These were used to generate standard curves.  20 µL each of human tendon, 
meniscus, chondrocyte, and periosteum cDNA samples were mixed together, creating a stock 
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solution at 40 ng/µL.  Because of the fact that the reverse transcriptase enzyme is only 80% 
efficient, 1 µg of RNA gave cDNA at a concentration of 40 ng/µL.  From the stock solution, 60 
µL of each standard concentration needed (20 ng/µL, 10 ng/µL, 5 ng/µL, 1 ng/µL, 0.5 ng/µL, 0.1 
ng/µL, and 0.01 ng/µL) were created. 
Quantitative Polymerase Chain Reaction 
     Following synthesis of cDNA from RNA samples, a quantitative polymerase chain reaction 
(qPCR) analysis was run to determine gene expression in the sample tissues.  Before starting the 
qPCR, centrifuges to be used were pre-cooled to 4°C.  cDNA samples were removed from the     
-80°C freezer, and primers were removed from a -20°C freezer.  Following sample removal, they 
were maintained in a grid-like pattern on the ice while thawing, as it aided in organizing the 
pipetting of a plate.  While samples and primers were thawing (around 30 min), the PCR 
instrument was turned.  The program was set up by opening the 7500 software application, and 
creating and naming a new experiment.  Under Experiment Properties, “7500 (96 wells),” 
“Quantitation—Relative Standard Curve,” “TaqMan Reagents,” and “Standard (2 hr to complete 
a run)” were selected.  Under Plate Setup, the Define Targets and Samples tab was entered.  
Under Define Targets, the target primer for the gene to be run was added.  For example, if 
running 18S rRNA, the target selected was 18S rRNA (Taq), FAM, NFQ-MGB.  Under Define 
Samples, both “Buffer Blank” and “Minus RT” were added, and all other samples, as well as 
positive controls, were input manually.  If 18S rRNA was being determined, standard 
concentrations of 0.01 ng/µL-5 ng/µL were used.  For all other genes, 0.1 ng/µL-20 ng/µL were 
chosen.  Under the Assign Targets and Samples tab, all the wells on the plate to be used were 
selected.  The appropriate target was added to the entire plate, and positive controls (run in 
triplicate), negative controls and buffer blank (singlets), and samples (duplicates) were entered 
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into the correct wells.  Under Run Method, the Tabular View tab was opened, and “Reaction 
Volume Per Well” was changed from 50 µL to 20 µL.  For 18S rRNA, “Number of Cycles” was 
changed from 40 to 35.  For any other gene analysis, the number of cycles was left at 40.  The 
reaction stage was set as follows: 
For 18S: 
 Holding Stage Holding Stage Cycling Stage 
Ramp Rate (%) 100.0 100.0 100.0 100.0 
Temperature (°C) 50.0 95.0 95.0 60.0 
Time 2:00 10:00 00:05 00:30 
 
For all other genes: 
 Holding Stage Holding Stage Cycling Stage 
Ramp Rate (%) 100.0 100.0 100.0 100.0 
Temperature (°C) 50.0 95.0 95.0 60.0 
Time 2:00 10:00 00:15 01:00 
 
At this point, the computer software was ready to run once the reaction plate had been inserted. 
     Next, the master mix was created.  The number of wells needed for the amplification reaction 
was calculated, and an additional 10% of the volume was supplemented to account for pipette 
carry-over.  The number of wells needed on the plate included positive controls, negative 
controls, buffer blank, and samples.  The master mix was created using the following recipe: (per 
well; a total amount was obtained by multiplying by the number of wells) 10 µL TaqMan 2X 
(Life Technologies, Grand Island, NY), 1 µL primer set, 8 µL sterile H2O, 1 µL cDNA.  Master 
mix was created in a 1.5-mL centrifuge tube, and tubes were stored at -80°C until needed. 
     After the cDNA was thawed, it was centrifuged at 1,000 g for 1 min at 4°C.  An Optical 96-
Well Reaction Plate (Life Technologies, Grand Island, NY) was placed in the holder, ensuring 
that nothing came in contact with the bottom of the plate.  The holder in the rack was placed on 
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the mixer, and 19 µL of master mix was added to the bottom of each well.  After the master mix 
had been added, one µL of cDNA was added to the side wall of each well, bringing the total 
volume per well to 20 µL.  The plate was sealed thoroughly with an optical adhesive film and 
squeegeed.   
     After the plate had been pipetted, it was processed.  The plate was centrifuged in an 
Eppendorf 5810R centrifuge at 1200 rpm for 4 min at 4°C to pull cDNA into the master mix 
(Eppendorf, Hauppauge, NY).  The plate was placed on a closed Eppendorf ThermoMixer 
(Eppendorf, Hauppauge, NY) at 1000 rpm for 5 min at 22°C to ensure thorough mixing of 
cDNA and master mix.  The plate was centrifuged again at 1200 rpm for 4 min at 4°.  The plate 
was placed into the instrument and Start Run was selected.  Once the run was complete, the data 
could be analyzed.  
Results 
Quantitative Polymerase Chain Reaction Analysis 
     The current study examined expression levels of five different genes for the purpose of 
assessing whether they are affected by scaffolds containing either HA or β -TCP.   The genes of 
interest are type I collagen, type II collagen, BSP, OC, and ON.  18S rRNA, β -actin, and P0 are 
used as reference controls since they are common housekeeping genes.  Results were obtained by 
analyzing RT-qPCR data.  The 18S rRNA gene is examined because it serves as an indicator of 
sample degradation, and the reliability of RT-qPCR data.  β -actin is used as a normalizing gene 
because it is assumed to be constantly expressed across a wide range of cell types.  For this 
reason, all other genes are normalized to β -actin during qPCR data analysis.  Figures 2A-F show 
plots of the expression of each gene of interest after normalization with β -actin.  Figures 3A-B (5 
and 20-week) present fold-change differences in the expression levels of these genes as a 
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function of scaffold type.  For reference purposes to identify the tissues from which gene 
expression data were obtained, histological images are included as Figures 4-7. 
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Figure 2B. Gene expression ratio of type II collagen normalized to β-actin.  The colors 
represent the two different scaffold types used as well as the two different time points. 
Figure 2A. Gene expression ratio of type I collagen normalized to β-actin.  The colors 
represent the two different scaffold types used as well as the two different time points. 
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Figure 2C. Gene expression ratio of BSP normalized to β-actin.  The colors represent the two 
different scaffold types used as well as the two different time points. 
Figure 2D. Gene expression ratio of OC normalized to β-actin.  The colors represent the two 
different scaffold types used as well as the two different time points. 
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Figure 2E. Gene expression ratio of ON normalized to β-actin.  The colors represent the two 
different scaffold types used as well as the two different time points. 
Figure 2F. Gene expression ratio of P0 normalized to β-actin.  The colors represent the two 
different scaffold types used as well as the two different time points. 
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Figure 2A illustrates gene expression of type I collagen after being normalized to β -actin.  Each 
bar represents a single normalized measurement taken for a given scaffold.  From this plot, it 
may be observed that in general type I collagen expression increased with both scaffold types 
from 5 to 20 weeks of implantation and that expression with β -TCP scaffolds appeared to be 
consistently higher than that with HA scaffolds.  The same conclusion can be drawn from Figure 
2C, which shows BSP expression levels.  Figure 2B presents type II collagen expression, which 
decreased with both scaffold types from 5 to 20 weeks of implantation, yet was higher at both 
time points with β -TCP scaffolding than with HA scaffolding.  Figure 2D illustrates expression 
levels of OC and shows that expression increased with both scaffold types from 5 to 20 weeks of 
implantation.  The same conclusion can be drawn from Figure 2E, which depicts expression 
Figure 3A.  Comparison by fold-change in distal phalanges developed on either HA or β-TCP scaffolds 
after 5 weeks of implantation in athymic mice.  Statistically significant (p < 0.05) differences between 
HA and B-TCP specimens for a specific gene are shown by *.  Data represent the mean value of three 
independent measurements and error bars represent standard error of mean values. 
* 
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levels of ON.  In both of these plots, it is observed that expression was consistently higher with 
the HA scaffolds than with β -TCP scaffolds. 
  
    
     Statistical t-tests performed for p < 0.05 indicated that there were statistically significant gene 
expression differences for tissue grown on β -TCP compared to HA scaffolds after 5 weeks of 
implantation.  The genes that were significantly different are shown in Figure 3A and included 
type I collagen and BSP.  After 20 weeks of implantation (Figure 3B), a statistically significant 
difference was found for type II collagen, in which its expression on β -TCP scaffolds exceeded 
that on HA.  In addition after 20 weeks of implantation, ON gene expression was statistically 
Figure 3B.  Comparison by fold-change in distal phalanges developed on either HA or β-TCP scaffolds 
after 20 weeks of implantation in athymic mice.  Statistically significant (p < 0.05) differences 
between specimens are shown by *.  Data represent the mean value of three independent 
measurements and error bars represent standard error of mean values. 
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significantly different (greater) when tissues were grown on HA scaffolds compared to β -TCP 
scaffolds.  Figures 3A-B suggest a trend in the expression of the genes of interest such that β -
TCP scaffolds induce greater expression than that of HA scaffolds.  However, this conclusion is 
not supported by statistically significant data against β -actin.   
     Figure 3A includes the analysis of a potential housekeeping gene, P0.  Data from 5-week 
implanted scaffolds indicated that this gene was statistically significantly different when tissues 
were grown on β -TCP and HA.  In this case, P0 could not be used as the normalizing gene in this 
study, and instead β -actin was selected in its place. 
Histological Analysis 
     In addition to qPCR, histological examination was correlated with RT-qPCR analysis.  
Samples had been previously fixed, sectioned, mounted on slides, and stained with T-blue by 
others in the laboratory.  The slides were viewed under a light microscope, and new images were 
obtained for this study.   
Figure 4 is an image taken of a 5-week implanted distal 
phalanx model developed on HA scaffolding.  The 
periosteum is wrapped about the scaffold and its cells do not 
appear to have traveled into the polymers at all.  One end of 
the scaffold had a chondrocyte-seeded PGA sheet sutured to 
it, but that scaffold has been lost or resorbed.  Chondrocytes, 
however, from the PGA sheet appear to have migrated 
somewhat into the HA scaffold. 
 
     Figure 5 illustrates an intact tissue-
engineered distal phalanx with periosteum 
2 mm 
S 
P 
C 
Figure 4.  A histological image showing a distal phalanx 
developed on an HA scaffold and harvested after 5 weeks of 
implantation in an athymic mouse.  The scaffold (S) appears 
black and white, and the periosteum (P) wrapped around it is 
stained blue.  The top portion of the scaffold appears to contain 
chondrocytes (C) that likely migrated from the engineered PGA 
scaffold seeded with those cells.  The overlying PGA scaffold has 
been lost in this specimen. 
 
Figure 5. A histological image showing a distal 
phalanx developed on an HA scaffold (S) and 
harvested after 20 weeks of implantation in an 
athymic mouse.  The image (left) depicts the 
entire construct section, while the enlarged 
image (right) highlights a region of the construct 
PGA sheet seeded with chondrocytes (C).  The 
periosteum (P) wrapped about the scaffold 
appears to have remained intact.  2 mm 
S 
P C 
S 
C 
400 µm 
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wrapped about 
its length and one sheet of 
PGA seeded with 
chondrocytes sutured to one of 
its ends.  Staining of the 
construct with T-blue suggests 
that both periosteal cells and 
chondrocytes have migrated 
into the HA scaffold (compare Figure 4 with its black HA scaffold).    
 
     Figure 6 shows a histologic image taken of a β -TCP sample at 5 weeks.  As with the 5-week 
HA sample, the periosteal cells do not appear to have penetrated the scaffold. The chondrocytes, 
however, appear to have begun migrating into the scaffold by 5 weeks as they do in the 5-week 
HA sample (Figure 4).   
 
 
 
 
 
 
Figure 6.  A histological image 
(right) showing a di tal phalanx 
developed on a β-TCP scaffold 
and harvested after 5 weeks of 
implantation in an athymic 
mouse.  The periosteal cells (P) 
and chondrocytes (C) do not 
appear to have penetrated the 
β-TCP scaffold (S).  The 
enlarged image (left) shows 
chondrocytes (stained purple).  
C 
S 
S 
P 
C 
200 µm 
2 mm 
Figure 7.  A histological image showing a 
distal phalanx developed on a β-TCP scaffold 
(S) and harvested after 20 weeks of 
implantation in an athymic mouse.  The 
cells, both periosteal (P) and chondrocyte 
(C), appear to have penetrated into the 
scaffold.  Portions of the periosteum 
wrapping the scaffold are absent in this 
section.  
 
2 mm 
S 
P 
C 
 
400 µm S 
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     Figure 7 is a histological image showing a β -TCP sample at 20 weeks.  Much like the HA 
sample at 20 weeks shown in Figure 5, both periosteal cells and chondrocytes appear to have 
penetrated into the scaffold.  The enlarged image shows a portion of the section where 
chondrocytes are concentrated, as evidenced by their purple staining.  
Discussion and Conclusions 
     The goal of the current study was to examine a tissue-engineered distal phalanx model, 
composed in part by one of two different scaffold types, seeded with either an HA or β -TCP 
mineral component, and to observe possible changes in development and expression of certain 
genes as a function of the scaffold mineral.  Each scaffold was wrapped about its length with a 
layer of human cadaveric periosteum.  One scaffold end was sutured with a chondrocyte-seeded 
PGA sheet.  The construct in this manner mimicked the morphology of a human distal phalanx.   
     The phalanx model specimens were previously designed and developed over 20 weeks of 
implantation in nude mice, and they were examined by histological means in other work.  This 
report re-examined some of the same specimens by histology and then investigated possible 
changes in the expression of several genes as a function of scaffold type (either HA or β -TCP).  
The present study of such genes from tissue-engineered phalanx models supported by either HA 
or β -TCP scaffolds is novel.  Little is known about any effects of a scaffold mineral on gene 
expression in bone- and cartilage-engineered constructs.  The data obtained suggest that β -TCP 
scaffolds support increased gene expression of type I collagen, type II collagen, BSP, OC, and 
ON following 5 weeks of construct implantation in athymic mice.  After 20 weeks of 
implantation in other athymic mice, the expression of type I collagen, type II collagen, and BSP 
appears to be enhanced by β -TCP scaffolding, while ON and OC are increased by HA 
scaffolding.  Statistically significant changes in expression of only certain of these genes were 
C 
30 | P a g e  
 
observed at either 5 or 20 weeks of implantation.  The basis for these observed changes in gene 
expression are unclear with respect to the scaffold mineral component, but possibly the 
expression differences could be attributable to differences in mineral particle sizes.  In this study, 
scaffolds of HA contained particles in the micron range, while scaffolds of β -TCP were in the 
sub-micron range.  It could be possible that the smaller sized β -TCP particles, compared to HA, 
provide easier attachment, migration/penetration, and proliferation/differentiation for osteoblasts 
and chondrocytes in these constructs.  In this regard, it is well documented that cells are 
responsive in gene expression and protein synthesis to the nature of the surfaces on which they 
reside.  The surface characteristics including surface particle size, density, roughness, 
hydrophobicity, hydrophilicity, and other features affect cells substantially and up- and down-
regulation of genes and proteins may normally result.19  In response to surface structure, different 
genes may be regulated in different ways, that is, some may be up-regulated while others may be 
down-regulated.  This study demonstrates such up- and down-regulation in genes from the same 
construct, but again the fundamental basis for these observations is unclear.   
    The number of constructs examined in this work is relatively small and it is likely that more 
conclusive data could be obtained from an extension of this study with larger sample numbers.  
In addition, it is also likely that improved data could be generated with constructs implanted for 
periods greater than 20 weeks.  Distal phalanx models without a mineral component have been 
implanted for up to 60 weeks in athymic mice in previous investigations.18  In these ways, the 
results presented here, showing changes in certain genes of distal phalanx models, may be 
supplemented and the interesting conclusion may be confirmed that a scaffold containing a 
mineral component can significantly influence gene expression and downstream protein 
synthesis and secretion. 
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Appendix 1 
Safety Considerations 
     Any scientific endeavor requires careful consideration to the issues of safety.  It is critical to be 
familiar with the proper methods by which to handle and use chemicals and laboratory instruments.  
     When using the freezer mill to grind tissue samples, liquid nitrogen is utilized.  Insulated gloves must 
be worn to protect skin from exposure to this compound.  
     This research makes use of human cadaveric tissue samples.  It is imperative that gloves be worn at all 
times to avoid contact with the tissue and reduce exposure to possible human diseases from said tissue.  In 
addition, the use of laboratory gloves ensures that samples themselves do not become contaminated.  RT-
qPCR is a very sensitive technique and will amplify any and all DNA present within a sample.  Therefore, 
precautions such as wearing gloves (as stated above), using RNase Away® (Life Technologies, Grand 
Island, NY), and avoiding accidental contact such as breathing and sneezing on samples, will all help 
decrease the risk of sample contamination.  
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     Caution must be taken during RNA isolation, reverse transcription, and qPCR, as the compounds used 
to perform the procedures are carcinogenic.  Again, gloves must be worn when handling such chemicals, 
and any contact with the skin, mouth, or eyes should be avoided. 
